AXSM Collar Strategy
AXSM (Axsome Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
AXSM (Axsome Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $12.11B, a beta of 0.59 versus the broader market, a 52-week range of 96.09-235.915, average daily share volume of 709K, a public-listing history dating back to 2015, approximately 712 full-time employees. These structural characteristics shape how AXSM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.59 indicates AXSM has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on AXSM?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current AXSM snapshot
As of May 15, 2026, spot at $228.54, ATM IV 37.90%, IV rank 13.22%, expected move 10.87%. The collar on AXSM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on AXSM specifically: IV regime affects collar pricing on both sides; compressed AXSM IV at 37.90% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 10.87% (roughly $24.83 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AXSM expiries trade a higher absolute premium for lower per-day decay. Position sizing on AXSM should anchor to the underlying notional of $228.54 per share and to the trader's directional view on AXSM stock.
AXSM collar setup
The AXSM collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AXSM near $228.54, the first option leg uses a $240.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AXSM chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AXSM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $228.54 | long |
| Sell 1 | Call | $240.00 | $5.75 |
| Buy 1 | Put | $220.00 | $6.80 |
AXSM collar risk and reward
- Net Premium / Debit
- -$22,959.00
- Max Profit (per contract)
- $1,041.00
- Max Loss (per contract)
- -$959.00
- Breakeven(s)
- $229.59
- Risk / Reward Ratio
- 1.086
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
AXSM collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on AXSM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$959.00 |
| $50.54 | -77.9% | -$959.00 |
| $101.07 | -55.8% | -$959.00 |
| $151.60 | -33.7% | -$959.00 |
| $202.13 | -11.6% | -$959.00 |
| $252.66 | +10.6% | +$1,041.00 |
| $303.19 | +32.7% | +$1,041.00 |
| $353.72 | +54.8% | +$1,041.00 |
| $404.25 | +76.9% | +$1,041.00 |
| $454.78 | +99.0% | +$1,041.00 |
When traders use collar on AXSM
Collars on AXSM hedge an existing long AXSM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
AXSM thesis for this collar
The market-implied 1-standard-deviation range for AXSM extends from approximately $203.71 on the downside to $253.37 on the upside. A AXSM collar hedges an existing long AXSM position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current AXSM IV rank near 13.22% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AXSM at 37.90%. As a Healthcare name, AXSM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AXSM-specific events.
AXSM collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AXSM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AXSM alongside the broader basket even when AXSM-specific fundamentals are unchanged. Always rebuild the position from current AXSM chain quotes before placing a trade.
Frequently asked questions
- What is a collar on AXSM?
- A collar on AXSM is the collar strategy applied to AXSM (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With AXSM stock trading near $228.54, the strikes shown on this page are snapped to the nearest listed AXSM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AXSM collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the AXSM collar priced from the end-of-day chain at a 30-day expiry (ATM IV 37.90%), the computed maximum profit is $1,041.00 per contract and the computed maximum loss is -$959.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AXSM collar?
- The breakeven for the AXSM collar priced on this page is roughly $229.59 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AXSM market-implied 1-standard-deviation expected move is approximately 10.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on AXSM?
- Collars on AXSM hedge an existing long AXSM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current AXSM implied volatility affect this collar?
- AXSM ATM IV is at 37.90% with IV rank near 13.22%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.